{{Rsnum
|rsid=3024866
|Gene=STAT4
|Chromosome=2
|position=191058115
|Orientation=minus
|GMAF=0.4642
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=STAT4
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 9.7 | 38.1 | 52.2
| HCB | 25.7 | 47.8 | 26.5
| JPT | 21.2 | 42.5 | 36.3
| YRI | 81.0 | 16.3 | 2.7
| ASW | 66.1 | 26.8 | 7.1
| CHB | 25.7 | 47.8 | 26.5
| CHD | 22.0 | 56.9 | 21.1
| GIH | 14.9 | 40.6 | 44.6
| LWK | 77.3 | 20.9 | 1.8
| MEX | 19.3 | 52.6 | 28.1
| MKK | 45.2 | 43.9 | 11.0
| TSI | 5.9 | 37.3 | 56.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=19644876
|Title=Association of STAT4 and BLK, but not BANK1 or IRF5, with primary antiphospholipid syndrome
}}

{{PMID Auto
|PMID=17932559
|Title=Association of STAT4 with rheumatoid arthritis in the Korean population.
|OA=1
}}

{{PMID Auto
|PMID=18579578
|Title=A risk haplotype of STAT4 for systemic lupus erythematosus is over-expressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5.
|OA=1
}}

{{PMID Auto
|PMID=19019891
|Title=STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk.
|OA=1
}}

{{PMID Auto
|PMID=23360093
|Title=Association study of STAT4 polymorphisms and type 1 diabetes in Northeastern Chinese Han population
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}